Primed for lethal battle: A step forward to enhance the efficacy and efficiency of stem cell transplantation therapy

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 3, 2009, Pages 527-

  Ogle, Molly E ^a   Yu, Shan Ping ^a   Wei, Ling ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B;

CELL PROTECTION; CELL SURVIVAL; EDITORIAL; HUMAN; ISCHEMIC PRECONDITIONING; MEDICAL PRACTICE; MOLECULAR MECHANICS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

BRAIN ISCHEMIA; FORECASTING; HUMANS; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION;

EID: 68749113958     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.06.003     Document Type: Editorial

References (4)

1. Theus M.H., Wei L., Cui L., Francis K., Hu X., Keogh C., et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol 210 (2008) 656-670
2. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogle M.E., Wang J.A., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135 (2008) 799-808
3. Liu X.B., Wang J.A., Ogle M.E., and Wei L. Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem 106 (2009) 903-911
4. Xu H., Ran R., Lu A., and Sharp F. Genomic response to hypoxia preconditioning in the adult mouse brain. Abstr Neurosci 413 (2008) 6